Biotech Values

[jq1234]

“Until all corrections have been completed and FDA has confirmed corrections of the violations and your firm’s compliance with [Current Good Manufacturing Practice regulations], FDA may withhold approval of any new applications or supplements listing your firm as a drug product manufacturer.”

If this were the only thing holding tL approval back, FDA would not have sent separate deficiency letter on tL in Jan.